Hyland’s Baby Teething Tablets Recalled After Being Linked to Baby Deaths in The US

Hyland’s Baby Teething Tablets in Australia have been recalled after the tablets were reportedly linked to deaths of babies, in cases that have emerged overseas.

Last year in the US, Hyland’s Baby Teething Tablets were linked to 400 ‘adverse events’ as well as the deaths of 10 babies.

As a result of these incidents, Hyland’s Baby Teething Tablets have been pulled from sale in Australia.

The Therapeutic Goods Administration (TGA) issued a recall notice this weekend in conjunction with distributor Kadac, stating the tablets are “unpredictable and could cause serious health problems” in babies and infants.

In Australia, five cases have been filed with the TGA, after babies used the tablets.

A company spokesperson told CHOICE, “Kadac is now recalling the tablets in Australia as a precautionary measure due to the potential safety risk that belladonna alkaloids can pose to children.”

“Hyland’s Baby Teething Gel is not affected by this recall. However, [Kadac] has decided that all Hyland’s baby teething products, including the gel, will no longer be marketed in Australia.”

The teething tablets have been sold at children’s hospitals, Terry White Chemists and Priceline Pharmacies.

The US FOOD and Drug Administration did an investigation in January on the tablets which found them to contain inconsistent amounts of a toxic substance in plants knowns as belladonna.

Unfortunately, homeopathic products are not tested by the TGA before they are sold in Australia.

Parents are being urged not to use Hyland’s Baby Teething Tablets or Nighttime Teething Tablets. If they have the product, they should return it to the place of purchase for a full refund.